SONG Ziyi, ZHANG Shengxiao, ZHAO Rong, QIAO Jun, SONG Shan, CHENG Ting, WANG Caihong, LI Xiaofeng. Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 821-830. DOI: 10.12290/xhyxzz.2022-0064
Citation: SONG Ziyi, ZHANG Shengxiao, ZHAO Rong, QIAO Jun, SONG Shan, CHENG Ting, WANG Caihong, LI Xiaofeng. Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 821-830. DOI: 10.12290/xhyxzz.2022-0064

Characteristics of Gut Microbiota and Their Association with Lymphocyte Subsets and Disease Activity in Ankylosing Spondylitis

Funds: 

National Natural Science Foundation of China 82001740

More Information
  • Corresponding author:

    LI Xiaofeng, E-mail: lxf_9859@sxmu.edu.cn

  • Received Date: February 15, 2022
  • Accepted Date: August 01, 2022
  • Available Online: September 05, 2022
  • Issue Publish Date: September 29, 2022
  •   Objective  To investigate the characteristics of gut microbiome and their associations with lymphocyte subsets and disease activity in patients with ankylosing spondylitis (AS).
      Methods  This study was a retrospective analysis. The subjects of the study were AS patients who were hospitalized in the Second Hospital of Shanxi Medical University from December 2019 to June 2020, as well as gender- and age-matched healthy controls (HCs). The fecal samples were collected, and the V3-V4 variable regions of 16S rRNA gene of gut microbiome were sequenced for bioinformatics analysis. Peripheral venous blood was collected from AS patients to determine peripheral blood lymphocyte subsets and disease activity indicators. Spearman correlation test was used to analyze the correlations between the relative abundances of gut microbiota and peripheral blood lymphocyte subsets as well as disease activity in AS patients.
      Results  A total of 62 AS patients (11 with low disease activity, 26 with high disease activity, and 25 with extremely high disease activity) and 62 healthy people who met the inclusion and exclusion criteria were enrolled. As for α-diversity, ACE and Chao1 indices were lower in AS than in HCs(P < 0.05). Bray curtis distance-based β-diversity analysis revealed significant difference in the microbial community between AS and HCs (P < 0.01). As for the composition of the gut microbiome, Firmicutes, Bacteroidetes, and Proteobacteria were the dominant phyla in the gut microbiota of both groups, but there were differences in the abundance of various bacteria at the phylum and genus levels. In Stamp analysis, fecal microbial communities in AS differed significantly from those in HCs, which were characterized by higher abundances of phylum Proteobacteria and Patescibacteria(all P < 0.05) and a lower abundance of phylum Firmicutes and Fusobacteriota (all P < 0.05). At the genus level, the abundances of Escherichia-Shigella, Klebsiella and Enterococcus were increased while those of Prevotella and Faecalibacterium were decreased in AS patients compared to HCs(all P < 0.05). Spearman correlation analysis showed that the relative abundances of Faecalibacterium, Ruminococcus and Klebsiella in AS patients were significantly positively correlated with disease activity or its related indicators(all P < 0.05). There were positive correlations between Agathobacter and T cell (r=0.302, P=0.017), CD4+T cell (r=0.310, P=0.014), B cell (r=0.292, P=0.021), Th2 cell (r=0.429, P < 0.001), Th17 cell (r=0.288, P=0.023), Streptococcus and B cell (r=0.270, P=0.034), Prevotella and Th1 cell (r=0.279, P=0.028), Th17 cell (r=0.262, P=0.040), CAG-352 and Th1 cell (r=0.283, P=0.030). There were negative correlations between Escherichia-Shigella and Th2 cell(r=-0.261, P=0.040), other Enterobacteriaceae and CD4+T cell (r=-0.255, P=0.046).
      Conclusions  The diversity of gut microbiota is reduced in AS patients. The abundance of pathogenic bacteria in AS patients is increased, which is correlated with changes in peripheral blood lymphocyte subsets and disease activity. Dysbiosis may be involved in the occurrence and development of AS.
  • [1]
    Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis-insights into pathogenesis[J]. Nat Rev Rheumatol, 2016, 12: 81-91. DOI: 10.1038/nrrheum.2015.133
    [2]
    Simone D, Al Mossawi MH, Bowness P. Progress in our understanding of the pathogenesis of ankylosing spondylitis[J]. Rheumatology (Oxford), 2018, 57: vi4-vi9. DOI: 10.1093/rheumatology/key001
    [3]
    Zhou C, Zhao H, Xiao XY, et al. Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis[J]. J Autoimmun, 2020, 107: 102360. DOI: 10.1016/j.jaut.2019.102360
    [4]
    Rosenbaum JT, Davey MP. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome[J]. Arthritis Rheum, 2011, 63: 3195-3198. DOI: 10.1002/art.30558
    [5]
    Costello ME, Ciccia F, Willner D, et al. Brief report: Intestinal Dysbiosis in Ankylosing Spondylitis[J]. Arthritis Rheumatol, 2015, 67: 686-691. DOI: 10.1002/art.38967
    [6]
    Dominguez-Lopez ML, Burgos-Vargas R, Galicia-Serrano H, et al. IgG antibodies to enterobacteria 60 kDa heat shock proteins in the sera of HLA-B27 positive ankylosing spondylitis patients[J]. Scand J Rheumatol, 2002, 31: 260-265. DOI: 10.1080/030097402760375133
    [7]
    van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria[J]. Arthritis Rheum, 1984, 27: 361-368. DOI: 10.1002/art.1780270401
    [8]
    Aranda-Valera IC, Garrido-Castro JL, Ladehesa-Pineda L, et al. How to calculate the ASDAS based on C-reactive protein without individual questions from the BASDAI: The BASDAI-based ASDAS formula[J]. Rheumatology (Oxford), 2020, 59: 1545-1549. DOI: 10.1093/rheumatology/kez480
    [9]
    Lynch SV, Pedersen O. The human intestinal microbiome in health and disease[J]. N Engl J Med, 2016, 375: 2369-2379. DOI: 10.1056/NEJMra1600266
    [10]
    Zhang L, Han R, Zhang X, et al. Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activity[J]. Clin Chim Acta, 2019, 497: 189-196. DOI: 10.1016/j.cca.2019.07.038
    [11]
    Chen Z, Qi J, Wei Q, et al. Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis[J]. Ann Transl Med, 2019, 7: 571. DOI: 10.21037/atm.2019.09.41
    [12]
    Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis[J]. Ann Rheum Dis, 2017, 76: 1614-1622. DOI: 10.1136/annrheumdis-2016-211064
    [13]
    Liu G, Hao Y, Yang Q, et al. The Association of Fecal Microbiota in Ankylosing Spondylitis Cases with C-reactive Protein and Erythrocyte Sedimentation Rate[J]. Mediators Inflamm, 2020, 2020: 8884324.
    [14]
    Ciccia F, Guggino G, Rizzo A, et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis[J]. Ann Rheum Dis, 2017, 76: 1123-1132. DOI: 10.1136/annrheumdis-2016-210000
    [15]
    Asquith M, Sternes PR, Costello ME, et al. HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome[J]. Arthritis Rheumatol, 2019, 71: 1642-1650. DOI: 10.1002/art.40917
    [16]
    Ebringer A, Ghuloom M. Ankylosing spondylitis, HLA-B27, and klebsiella: cross reactivity and antibody studies[J]. Ann Rheum Dis, 1986, 45: 703-704. DOI: 10.1136/ard.45.8.703
    [17]
    Pedersen SJ, Maksymowych WP. The Pathogenesis of Ankylosing Spondylitis: an Update[J]. Curr Rheumatol Rep, 2019, 21: 58. DOI: 10.1007/s11926-019-0856-3
    [18]
    Antoniou AN, Lenart I, Kriston-Vizi J, et al. Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication[J]. Ann Rheum Dis, 2019, 78: 74-82. DOI: 10.1136/annrheumdis-2018-213532
    [19]
    Clegg DO, Reda DJ, Abdellatif M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs coopera-tive study[J]. Arthritis Rheum, 1999, 42: 2325-2329. DOI: 10.1002/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C
    [20]
    Liu B, Yang L, Cui Z, et al. Anti-TNF-α therapy alters the gut microbiota in proteoglycan-induced ankylosing spondylitis in mice[J]. Microbiologyopen, 2019, 8: e927.
    [21]
    Ciccia F, Guggino G, Rizzo A, et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis[J]. Ann Rheum Dis, 2015, 74: 1739-1747. DOI: 10.1136/annrheumdis-2014-206323
    [22]
    Chua WJ, Truscott SM, Eickhoff CS, et al. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection[J]. Infect Immun, 2012, 80: 3256-3267. DOI: 10.1128/IAI.00279-12
    [23]
    Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine[J]. FEMS Microbiol Lett, 2009, 294: 1-8. DOI: 10.1111/j.1574-6968.2009.01514.x
    [24]
    Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T cell development by a commensal bacterium of the intestinal microbiota[J]. Proc Natl Acad Sci U S A, 2010, 107: 12204-12209. DOI: 10.1073/pnas.0909122107
    [25]
    Eastmond CJ, Willshaw HE, Burgess SE, et al. Frequency of faecal Klebsiella aerogenes in patients with ankylosing spondylitis and controls with respect to individual features of the disease[J]. Ann Rheum Dis, 1980, 39: 118-123. DOI: 10.1136/ard.39.2.118
    [26]
    Zhang L, Zhang YJ, Chen J, et al. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review[J]. Microb Pathog, 2018, 117: 49-54. DOI: 10.1016/j.micpath.2018.02.020
    [27]
    van Bohemen CG, Grumet FC, Zanen HC. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia[J]. Immunology, 1984, 52: 607-610.
    [28]
    Ebringer RW, Cawdell DR, Cowling P, et al. Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease[J]. Ann Rheum Dis, 1978, 37: 146-151. DOI: 10.1136/ard.37.2.146
    [29]
    Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progres-sion in early axial spondylarthritis[J]. Arthritis Rheum, 2012, 64: 1388-1398. DOI: 10.1002/art.33465
    [30]
    Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients[J]. Genome Med, 2017, 9: 103. DOI: 10.1186/s13073-017-0490-5
    [31]
    Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease[J]. Immunology, 2017, 151: 363-374. DOI: 10.1111/imm.12760
  • Related Articles

    [1]JIANG Wenli, HUANG Tian, WANG Furui, ZHOU Guangbo, ZHENG Ya, WANG Yuping, HU Zenan. A Bibliometric Analysis of the Relationship Between Oral Microbiome and Digestive System Diseases[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0877
    [2]JIA Chunyu, WANG Gangan, WANG Jiahui, CHEN Gang, ZHENG Ke, LI Xuemei. Correlation Between Neutrophil-to-lymphocyte Ratio and eGFR in Diabetic Patients: A Cross-sectional Analysis Based on NHANES Data[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0908
    [3]WU Ziyan, FENG Futai, LI Haolong, XU Honglin, ZHANG Shulan, LI Yongzhe. Quantitative Analysis of Mitochondrial Damage in T Lymphocytes from Patients with Autoimmune Diseases and Evaluation of Its Clinical Value[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 991-998. DOI: 10.12290/xhyxzz.2023-0256
    [4]HUANG Biqing, LI Lanjuan. The Impact of Gut Microbiota on Vaccine Immune Efficacy and Potential Mechanisms[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 939-944. DOI: 10.12290/xhyxzz.2023-0173
    [5]XIE Lantian, RUAN Guiren, LIU Xiaoqing, ZHANG Lifan, ZHANG Yueqiu, QIU Zhifeng, SHI Xiaochun. Changes of Peripheral Blood Lymphocyte Subsets in 212 Active Tuberculosis Patients: A Uni-centered Descriptive Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(1): 131-138. DOI: 10.12290/xhyxzz.2022-0645
    [6]FANG Yuan, PAN Yuanlong, ZHU Baoli. Human Gut Microbiome and Diseases: Current Status, Opportunity and Challenges[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 713-718. DOI: 10.12290/xhyxzz.2022-0288
    [7]LI Yang, WANG Liuping, HUANG Jin, FAN Xiangmin, TIAN Feng. Application of Human-Computer Interaction Technology in Ancillary Diagnosis of Nervous System Diseases: Current Situation and Prospect[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 608-613. DOI: 10.12290/xhyxzz.2021-0522
    [8]Rui ZHANG, Yan BAI, Wei WEI, Mei-yun WANG. Application of Magnetic Resonance-guided Focused Ultrasound Therapy in Central Nervous System Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 54-61. DOI: 10.3969/j.issn.1674-9081.20190214
    [9]Yu-hao JIAO, Bei-di CHEN, Xuan ZHANG. Interplay between the Gut Microbiota and the Innate Immune System[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 257-262. DOI: 10.3969/j.issn.1674-9081.2019.03.012
    [10]Yu-hao JIAO, Feng-chun ZHANG. New Insights into Research on the Role of Gut Microbiota in Human Immune System[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 193-196. DOI: 10.3969/j.issn.1674-9081.2019.03.001
  • Cited by

    Periodical cited type(4)

    1. 彭记棚,熊鸿,罗丰,袁雪梅,杨孝余,周勇,申敏,马武开,姚血明. 基于肠道菌群探讨中西医治疗强直性脊柱炎的研究进展. 风湿病与关节炎. 2024(02): 52-56 .
    2. 朱雅文,黄传兵,程园园,钱爱. 固本培元法治疗强直性脊柱炎. 中医学报. 2024(07): 1413-1416 .
    3. 陈丽珍,施进兴,柳晓林,徐胜杰,林文平. 强直性脊柱炎患者T淋巴细胞亚群水平变化与疾病严重程度及预后的相关性分析. 西安交通大学学报(医学版). 2024(05): 769-775 .
    4. 王丽莹,闻志轲,孟庆良. 肠道菌群与强直性脊柱炎相关性研究进展. 中医学报. 2023(09): 1823-1828 .

    Other cited types(3)

Catalog

    Article Metrics

    Article views (3522) PDF downloads (54) Cited by(7)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close